Collectively, both genetic and pharmacologic inhibition of NOX2 in obese mice and PA-treated hiPSC-aCMs abrogates ion channel and structural remodeling and prevents obesity-mediated AF in part by transcriptional regulation of PITX2. The gene discussed is PITX2; the disease is atrial fibrillation.